Fig. 3: Concentric cardiac remodelling non-hypertensive pathway activity in schizophrenia vs healthy controls. | Translational Psychiatry

Fig. 3: Concentric cardiac remodelling non-hypertensive pathway activity in schizophrenia vs healthy controls.

From: Adipose tissue dysfunction, inflammation, and insulin resistance: alternative pathways to cardiac remodelling in schizophrenia. A multimodal, case–control study

Fig. 3

A Markers of adipocyte dysfunction. B Markers of dyslipidaemia or liver dysfunction (e.g. NAFLD). C Markers of inflammation, dysglycaemia, and endothelial dysfunction. p Kruskal–Wallis non-parametric test p value, HC healthy control, CS chronic schizophrenia, ALP alkaline phosphatase, GGT gamma-glutamyltransferase, ALT alanine aminotransferase, LDL and HDL low- and high-density lipoprotein, hsCRP high-sensitivity C-reactive protein, HOMA-IR Homeostatic Model Assessment for Insulin Resistance.

Back to article page